Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery Disease

NCT00180544 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
167
Enrollment
INDUSTRY
Sponsor class

Stopped Device superceded by next generation device. Enrollment stopped, long term follow up was completed in August of 2004.

Conditions

Interventions

Sponsor

Abbott Medical Devices